EUVIMEDEUVIMED entdecken
Crossref

Retsat promotes synovial mesenchymal stem cell senescence and aggravates osteoarthritis by inhibiting the PPARγ/RXR heterodimerization pathway

Yanbin Shi, Song Wu, Chi Liang, Li-Na Zhang, Xu Cao, Junjie Huang, Wenxiu Zhang

Osteoarthritis and Cartilage · 2026

DOI: 10.1016/j.joca.2026.06.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026. Verfasst von Yanbin Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha City, Hunan Province 410013, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cellular Senescence, PPAR gamma, Synovial Membrane. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Osteoarthritis (OA), a prevalent degenerative joint disorder, lacks curative conventional therapies. Stem cell therapy is being subjected to increasing attention in the realm of OA treatment. This study aimed to investigate the metabolic changes in senescent synovial mesenchymal stem cells (SMSCs) and the role and molecular mechanisms of the retinol metabolism pathway enzyme retinol saturase (Retsat) in SMSCs in the regulation of OA. METHOD: Metabolomic profiling compared young and aged OA-free patient-derived SMSCs, identifying trans-13,14-dihydroxyretinol as a key discriminatory metabolite. Retsat expression was modulated using siRNA interference, followed by functional assessments in vitro, including cell proliferation, senescence, inflammation, and in vivo using a murine OA model. RESULTS: Metabolomics revealed significant differences between young and elderly SMSCs. Trans-13,14-dihydroxyretinol, a Retsat substrate, was the primary differential metabolite (Fold Change = 14.585, P = 0.012), highlighting altered retinol metabolism. Silencing Retsat promoted proliferation (mean difference 77.67, 95% confidence interval: [67.33, 88.00]) and inhibited senescence (-35.20, [-45.30, -25.10]) and inflammation in senescent SMSCs. Moreover, Retsat inhibited PPARγ/RXR pathway activation; conversely, PPARγ/RXR activation enhanced the viability-promoting effects of Retsat silencing (44.00 [26.77, 61.23]). In vivo, Retsat-silenced senescent SMSCs ameliorated OA progression in middle-aged mice, significantly reducing OARSI scores, inflammation and the levels of senescence marker p21 (cartilage -0.103 [-0.162, -0.045] synovial -0.087, [-0.141, -0.033]). Furthermore, Retsat silencing promoted proliferation in senescent bone marrow mesenchymal stem cells (BMSCs). CONCLUSION: Silencing Retsat improved cartilage repair in OA by activating the PPARγ/RXR heterodimer pathway and enhancing the activity of senescent SMSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsCellular SenescencePPAR gammaSynovial MembraneOsteoarthritisAnimalsHumansMiceCell ProliferationFemaleAgedMaleSignal TransductionMetabolomicsMiddle Aged

Stichwörter der Autor:innen

MetabolomicsOsteoarthritisRetsatSenescenceSynovial mesenchymal stem cells

Substanzen

PPAR gamma

Autor:innen und Institutionen

  • Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha City, Hunan Province 410013, China.
  • Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha City, Hunan Province 410013, China. Electronic address: zhangwenxiu19850218@outlook.com.

Förderung

  • Hunan Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Shi, Y., Wu, S., Liang, C., Zhang, L. N., Cao, X., Huang, J., & Zhang, W. (2026). Retsat promotes synovial mesenchymal stem cell senescence and aggravates osteoarthritis by inhibiting the PPARγ/RXR heterodimerization pathway. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2026.06.012

Vancouver

Shi Y, Wu S, Liang C, Zhang LN, Cao X, Huang J, et al. Retsat promotes synovial mesenchymal stem cell senescence and aggravates osteoarthritis by inhibiting the PPARγ/RXR heterodimerization pathway. Osteoarthritis and Cartilage. 2026. doi:10.1016/j.joca.2026.06.012

BibTeX
@article{Shi2026,
  author = {Shi, Yanbin and Wu, Song and Liang, Chi and Zhang, Li-Na and Cao, Xu and Huang, Junjie and Zhang, Wenxiu},
  title = {Retsat promotes synovial mesenchymal stem cell senescence and aggravates osteoarthritis by inhibiting the PPARγ/RXR heterodimerization pathway},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  doi = {10.1016/j.joca.2026.06.012}
}
Kostenlos starten →